{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:06:07Z","timestamp":1784099167073,"version":"3.55.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Radiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Some primary pancreatic cancer lesions are located deep in the abdomen and adjacent to major blood vessels, which leads to procedural risk and low success rates of percutaneous biopsy. This situation creates substantial obstacles for pathological diagnosis and biomarker detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a 54-year-old female patient diagnosed with malignant pancreatic body carcinoma. The primary tumor was in close proximity to the splenic artery and accompanied by omental metastatic nodules. After multidisciplinary team discussion, we selected the safely accessible omental metastatic lesions as alternative biopsy targets and performed core needle biopsy under contrast-enhanced ultrasound (CEUS) guidance for tissue sampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pathological examination confirmed adenocarcinoma, and the immunophenotype was consistent with a pancreatobiliary origin. Immunohistochemical staining revealed high CLDN18.2 expression. The patient was subsequently enrolled in a clinical trial for CLDN18.2-directed combination therapy. Serial imaging follow-up demonstrated measurable shrinkage of both the primary tumor and metastatic lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>When imaging and clinical evaluations strongly indicate a solitary pancreatic malignancy and safely accessible metastatic lesions are present, the strategy of CEUS-guided alternative target biopsy serves as a viable approach to acquire tissue specimens and conduct biomarker testing. Nonetheless, its diagnostic concordance and clinical generalizability remain to be validated in large-sample studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fradi.2026.1800543","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:39Z","timestamp":1784095899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Alternative biopsy targets plus CEUS-guided omental puncture: enabling CLDN18.2 detection and precision therapy enrollment in pancreatic cancer"],"prefix":"10.3389","volume":"6","author":[{"given":"Hang","family":"Yin","sequence":"first","affiliation":[{"name":"Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Affiliated Hospital of Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1038\/s41467-023-38064-w","article-title":"HAPLN1 potentiates peritoneal metastasis in pancreatic cancer","volume":"14","author":"Wiedmann","year":"2023","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/0008-5472.CAN-24-0744","article-title":"MICAL2 promotes pancreatic cancer growth and metastasis","volume":"85","author":"Garg","year":"2025","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","article-title":"Cancer biomarkers: emerging trends and clinical implications for personalized treatment","volume":"187","author":"Passaro","year":"2024","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"102719","DOI":"10.1016\/j.ctrv.2024.102719","article-title":"Pancreatic cancer biomarkers: a pathway to advance in personalized treatment selection","volume":"125","author":"Brozos-V\u00e1zquez","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40644-020-00332-z","article-title":"Greater omentum imaging-reporting and data system: establishing the grade of benign and malignant lesions of the greater omentum using ultrasonography","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Imaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/MPA.0000000000001857","article-title":"Incidence, treatment, and survival of synchronous peritoneal metastases in pancreatic cancer: update of a nationwide cohort","volume":"50","author":"Rijken","year":"2021","journal-title":"Pancreas"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40169-019-0221-1","article-title":"Pancreatic cancer microenvironment: a current dilemma","volume":"8","author":"Uzunparmak","year":"2019","journal-title":"Clin Transl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5420","DOI":"10.1038\/s41598-020-62416-x","article-title":"Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes","volume":"10","author":"Pausch","year":"2020","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1021\/acssensors.2c01468","article-title":"Ultrasound molecular imaging and its applications in cancer diagnosis and therapy","volume":"7","author":"Zhang","year":"2022","journal-title":"ACS Sens"},{"key":"B12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13089-025-00444-2","article-title":"Advances and innovations in ultrasound-based tumor management: current applications and emerging directions","volume":"17","author":"Rui","year":"2025","journal-title":"Ultrasound J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/cancers14030481","article-title":"Contrast-enhanced ultrasound for monitoring treatment response in different stages of hepatocellular carcinoma","volume":"14","author":"Faccia","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1007\/s00330-025-11489-1","article-title":"Safety and efficacy evaluation of contrast-enhanced ultrasound-guided omental biopsy: a single-center prospective study","volume":"35","author":"Chen","year":"2025","journal-title":"Eur Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e7467","DOI":"10.1002\/cam4.7467","article-title":"Reliability, diagnostic value, and diagnostic yield of ultrasound-guided percutaneous core needle biopsy for peritoneal lesions","volume":"13","author":"Arslan","year":"2024","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.cgh.2020.02.054","article-title":"Burden of pancreatic cancer: from epidemiology to practice","volume":"19","author":"Khalaf","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/wjg.v27.i27.4298","article-title":"Pancreatic cancer: a review of epidemiology, trend, and risk factors","volume":"27","author":"Hu","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"17588359231217967","DOI":"10.1177\/17588359231217967","article-title":"Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer","volume":"16","author":"Kubota","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the know your tumor registry trial","volume":"21","author":"Pishvaian","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Radiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1800543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:11:41Z","timestamp":1784095901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1800543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":19,"alternative-id":["10.3389\/fradi.2026.1800543"],"URL":"https:\/\/doi.org\/10.3389\/fradi.2026.1800543","relation":{},"ISSN":["2673-8740"],"issn-type":[{"value":"2673-8740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1800543"}}